Consensus Allakos Inc.

Equities

ALLK

US01671P1003

Real-time Estimate Cboe BZX 02:20:42 2024-04-16 pm EDT 5-day change 1st Jan Change
1.065 USD -1.39% Intraday chart for Allakos Inc. -10.00% -60.44%

Evolution of the average Target Price on Allakos Inc.

Price target over the last 5 years

History of analyst recommendation changes

2df1c0bb438f4164d18e69.ddz5_QpispN3ORiR6OMbH26vBG_1jsjJMqHyx6JKe_w.LLfNjEk32t4_WErTvbR0cAWaSzmT6IaFB9a1hcF6MZIqj5S5Ui7BqyBwew~53dc3c302b10a4946233d3e9e7c3bf35
JMP Securities Adjusts Allakos' Price Target to $3 From $10, Maintains Market Outperform Rating MT
Barclays Trims Allakos' Price Target to $1 From $1.50, Maintains Underweight Rating MT
Jefferies Downgrades Allakos to Hold From Buy, Adjusts Price Target to $1.50 From $6 MT
Cantor Fitzgerald Downgrades Allakos to Neutral From Overweight MT
Lifesci Capital Downgrades Allakos to Market Perform From Outperform MT
William Blair Upgrades Allakos to Outperform From Market Perform MT
JMP Securities Adjusts Price Target on Allakos to $10 From $11, Maintains Market Outperform Rating MT
Barclays Adjusts Price Target on Allakos to $1.50 From $2.50, Maintains Underweight Rating MT
JMP Securities Initiates Allakos With Outperform Rating, Price Target is $11 MT
Jefferies Upgrades Allakos to Buy From Hold, Raises Price Target to $9 From $6 MT
Piper Sandler Starts Allakos at Overweight With $22 Price Target MT
SMBC Nikko Downgrades Allakos to Underperform From Neutral, Lowers Price Target to $2 From $4 MT
Cantor Fitzgerald Trims Price Target on Allakos to $7 From $10, Maintains Overweight Rating MT
Goldman Sachs Adjusts Allakos' Price Target to $4 from $10, Keeps Neutral Rating MT
Barclays Adjusts Allakos' Price Target to $2.50 from $7, Keeps Underweight Rating MT
Morgan Stanley Adjusts Price Target for Allakos to $6 From $8, Maintains Equalweight Rating MT
Barclays Adjusts Allakos' Price Target to $7 From $8, Reiterates Underweight Rating MT
Goldman Sachs Adjusts Allakos' Price Target to $11 From $60, Maintains Neutral Rating MT
SVB Leerink Adjusts Allakos' Price Target to $13 from $17, Maintains Market Perform Rating MT
Morgan Stanley Adjusts Allakos Price Target to $8 From $10, Reiterates Equalweight Rating MT
HC Wainwright Adjusts Allakos' Price Target to $20 From $230, Reiterates Buy Rating MT
SMBC Nikko Upgrades Allakos to Neutral from Underperform, Adjusts Price Target to $9 from $40 MT
Cantor Fitzgerald Adjusts Allakos' Price Target to $25 from $218, Keeps Overweight Rating MT
Goldman Sachs Adjusts Allakos' Price Target to $60 From $122, Maintains Neutral Rating MT
Morgan Stanley Adjusts Allakos' Price Target to $10 From $86, Keeps Equalweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
1.08 USD
Average target price
2.9 USD
Spread / Average Target
+168.52%
High Price Target
7 USD
Spread / Highest target
+548.15%
Low Price Target
1 USD
Spread / Lowest Target
-7.41%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Allakos Inc.

Jefferies & Co.
Barclays
JMP Securities
Cantor Fitzgerald
LifeSci Capital
William Blair & Co.
Piper Sandler
SMBC Nikko
Goldman Sachs
Morgan Stanley
SVB Leerink
HC Wainwright
Cowen
BofA Securities
  1. Stock Market
  2. Equities
  3. ALLK Stock
  4. Consensus Allakos Inc.